Further considerations for placebo controls in surgical trials
| dc.contributor.author | Campbell, Marion K | |
| dc.contributor.author | Beard, David J | |
| dc.contributor.author | Blazeby, Jane M | |
| dc.contributor.author | Cousins, Sian | |
| dc.contributor.author | ASPIRE group | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2023-06-12T11:53:00Z | |
| dc.date.available | 2023-06-12T11:53:00Z | |
| dc.date.issued | 2023-06-10 | |
| dc.description | Acknowledgements The authors wish to thank those who attended the ASPIRE expert-consensus workshop in Oxford in 2018 (1), and the dissemination event held the day prior to the workshop in June 2022, including Shyama Chadha, Katie Gordon, Richard Emsley, Catherine Blewett, Rachel Kelly, Peter Hutchinson, Gemma Ainsworth, Alaa Adil Ibrahim Fadl Elseed, Andrew You, Catriona McDaid, Gavin Murphy, Harneet Mankoo, Mark Smith, Prashant Patel and Rob Langley. The authors also wish to thank Katy Chalmers for note-taking at the workshop. The ASPIRE group includes co-authors: Ahmed Ahmed, Imperial College London, UK; Rasha Al-Lamee, Imperial College London, UK; David Anderson, University of Sydney, Australia; Natalie Blencowe, University of Bristol, UK; Jonathan Cook, University of Oxford, UK; Brian H Cuthbertson, Sunnybrook Health Sciences Centre, Canada; Manuela Ferreira, University of Sydney, Australia; Matt Gardiner, University of Oxford, UK; Katie Gillies, University of Aberdeen, UK; José Miola, University of Leeds, UK; John Norrie, University of Edinburgh, UK; Tom Pinkney, University of Birmingham, UK; Jonathan Pugh, University of Oxford, UK; Maroeska Rovers, Radboud University Medical Centre, Netherlands; Deborah Stocken, University of Leeds, UK; Matt Westmore, Health Research Authority, UK. Funding This study was funded by the National Institute for Health and Care Research Bristol Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The study funders had no role in the design of the study, data collection, data analysis, interpretation of data, writing of the report or the decision to submit the article for publication. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 6 | |
| dc.format.extent | 1012853 | |
| dc.identifier | 254600747 | |
| dc.identifier | 821cdbd5-226b-4bdb-b38e-6e6416829aff | |
| dc.identifier | 37301819 | |
| dc.identifier | 85161665992 | |
| dc.identifier.citation | Campbell, M K, Beard, D J, Blazeby, J M, Cousins, S & ASPIRE group 2023, 'Further considerations for placebo controls in surgical trials', Trials, vol. 24, no. 1, 391. https://doi.org/10.1186/s13063-023-07417-7 | en |
| dc.identifier.doi | 10.1186/s13063-023-07417-7 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1745-6215 | |
| dc.identifier.other | PubMedCentral: PMC10257825 | |
| dc.identifier.other | ORCID: /0000-0001-7890-2854/work/140898846 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20822 | |
| dc.identifier.vol | 24 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Trials | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | R | en |
| dc.title | Further considerations for placebo controls in surgical trials | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Campbell_etal_T_Further_Considerations_For_VoR.pdf
- Size:
- 989.11 KB
- Format:
- Adobe Portable Document Format
